Literature DB >> 6747810

Intestinal absorption of carboxyfluorescein entrapped in liposomes in comparison with its administration with lipid-surfactant mixed micelles.

N Hashida, M Murakami, H Yoshikawa, K Takada, S Muranishi.   

Abstract

The absorption of carboxyfluorescein (CF) entrapped in liposomes from the small intestine was investigated in vivo using bile fistula rats. Within the intestine CF was not metabolized, but 32% of the entrapped CF was released for 3 h from the liposomes when incubated with luminal incubation solution. The data of CF disappearance from the intestinal lumen and of CF plasma concentration showed that no apparent difference was observed between administration of the liposomal CF and that of free dye. Especially in initial 60 min after administration of liposomal CF, the plasma concentration was obviously lower than that in free CF administration. On the contrary, the coadministration of 40 mM lipid-surfactant mixed micelles induced a remarkable promotive effect on the absorption of free CF already in the early periods of the initial 60 min. When liposomal CF was administered into the intestinal lumen of thoracic duct-cannulated rats, the concentration in lymph was lower than that in plasma. Intramural injection of liposomal CF into intestinal wall, however, showed a much higher concentration in lymph than that in plasma. These findings suggest that liposomal entrapment of CF has rather difficulty to be absorbed through the intestinal mucosa, while lipid-surfactant mixed micelles exert a remarkable promotive effect on the absorption of CF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6747810     DOI: 10.1248/bpb1978.7.195

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  6 in total

1.  Modification of intestinal absorption of drugs by lipoidal adjuvants.

Authors:  S Muranishi
Journal:  Pharm Res       Date:  1985-05       Impact factor: 4.200

Review 2.  Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

Authors:  Shuang Cai; Qiuhong Yang; Taryn R Bagby; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2011-06-25       Impact factor: 15.470

3.  Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.

Authors:  Arvind Thakkar; Preshita Desai; Sushma Chenreddy; Jalpa Modi; Astrid Thio; Wael Khamas; David Ann; Jeffrey Wang; Sunil Prabhu
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

4.  Evaluation of an oleic acid water-in-oil-in-water-type multiple emulsion as potential drug carrier via the enteral route.

Authors:  N Oba; H Sugimura; Y Umehara; M Yoshida; T Kimura; T Yamaguchi
Journal:  Lipids       Date:  1992-09       Impact factor: 1.880

5.  Effect of oleic Acid vesicles on intestinal absorption of carboxyfluorescein in rats.

Authors:  M Murakami; H Yoshikawa; K Takada; S Muranishi
Journal:  Pharm Res       Date:  1986-02       Impact factor: 4.200

6.  Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles.

Authors:  Arvind Thakkar; Sushma Chenreddy; Jeffrey Wang; Sunil Prabhu
Journal:  Cell Biosci       Date:  2015-08-21       Impact factor: 7.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.